JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 3. (A) Yearly loss in CLR >20% (black bars) and <20% (white bars) in 28 patients treated with 90Y-DOTATOC who had 0–4 risk factors from hypertension, diabetes, age >60 y, and maximal per-cycle renal radiation dose >14 Gy. (B) Yearly loss in CLR >20% and <20% in 65 patients treated with 90Y-DOTATOC or 177Lu-DOTATATE who had 0–5 risk factors from hypertension, diabetes, age >60 y, cumulative renal radiation dose, and maximal per cycle radiation dose.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE